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Asymmetric sulfoxidation of sulfur-containing L-amino acid was successfully achieved 2 
through bioconversion using IDO, which is an Fe(II)/α-ketoglutarate-dependent dioxygenase 3 
previously found in Bacillus thuringiensis strain 2e2.  IDO catalyzed sulfoxidation of 4 
L-methionine, L-ethionine, S-methyl-L-cysteine, S-ethyl-L-cysteine, and S-allyl-L-cysteine 5 
into corresponding (S)-configured sulfoxides such as (+)-methiin and (+)-alliin, which are 6 
responsible for valuable physiological activities in mammals, and have high stereoselectivity.  7 
Here, we established an effective preparative laboratory scale production method to obtain 8 





1. Introduction 1 
 Chiral sulfoxides are noteworthy reagents in a wide range of industrial fields.  They 2 
have been used as chiral building blocks and chiral auxiliaries in the organic synthesis of 3 
other optically active compounds.
1
  In the medicinal and pharmaceutical industry, chiral 4 
sulfoxide derivatives are of special importance because of their high biological activity.
2
  5 
Also, chiral sulfinyl groups occur naturally in some functionalized amino acids, including 6 
L-methionine (S)-sulfoxide [(+)-MetSO] in the methionine metabolism of mammals
3
 and 7 
L-cysteine-related sulfoxides found in Allium and Brassica species.
4,5
  In particular, 8 
S-methyl-L-cysteine (S)-sulfoxide [(+)-methiin] and S-allyl-L-cysteine (S)-sulfoxide 9 





 anti-inflamatory,9 anti-diabetic,10,11 anti-Alzheimer’s,12 and 11 
anti-cholesterolemic
13
 effects.  Also, S-ethyl-L-cysteine (S)-sulfoxide[(+)-ethiin] is known 12 
to be a minor flavor precursor in Allium species.
14
   13 
 To date, many production methods for chiral sulfoxides have been established using 14 
chemical and biological catalysts.
15
  In particular, biocatalytic oxidation of prochiral sulfides 15 
is an advantageous method because of the highly stereoselective and chemoselective 16 
properties of oxidizing enzymes such as monooxygenases, dioxygenases, and peroxidases. 17 
16-18
  A cyclohexanone monooxygenase of Acinetobacter calcoaceticus
19
 and 18 
flavin-containing monooxygenases (FMOs) in mammalian microsomes
20-22
 are known to 19 
promote sulfoxidation activity in sulfur-containing amino acids.   20 
 Previously, we found that an Fe(II)/α-ketoglutarate-dependent dioxygenase (IDO) 21 
from Bacillus thuringiensis strain 2e2 catalyzed hydroxylation of L-isoleucine into 22 
(2S,3R,4S)-4-hydroxyisoleucine.
23,24
  In addition to stereoselective hydroxylation, IDO also 23 
catalyzed stereoselective sulfoxidation of L-methionine and L-ethionine.
25
   24 
In this study, we also found that IDO catalyzed asymmetric oxidation of several 25 
4 
 
other sulfur-containing L-amino acids with high yield.  Furthermore, we demonstrated dried 1 
microbial cells containing IDO (IDO-catalyst) was useful to apply to the preparative 2 
laboratory scale production of valuable chiral sulfoxides such as (+)-MetSO, (+)-methiin, 3 




2. Results and Discussion 1 
 2 
2.1. Conversion of sulfur-containing L-amino acids 3 
We investigated the IDO-catalyzed oxidation of multiple sulfur-containing 4 
L-amino acids (Table 1).  The dried cell powder of IDO-expressing E. coli 5 
(IDO-catalyst) was used as a biocatalyst for oxidation.  IDO-catalyst converted several 6 
S-alkyl-L-homocysteins like L-methionine (Met) and L-ethionine (Eth) and several 7 
S-alkyl-L-cysteines, such as S-methyl-L-cysteine (SMCys), S-ethyl-L-cysteine (SECys), 8 
and S-allyl-L-cysteine (SACys), of which Met, SMCys, SECys, and SACys were better 9 
substrates of IDO-catalyst (complete conversion of 10 mM substrate in most cases).  10 
IDO-catalyst conversion of Eth, which had a longer alkyl chain than Met, was 11 
somewhat less (67% conversion).  IDO-catalyst showed 0.064 μmol/min/mg (U/mg) of 12 
specific activity when Met was used as a substrate.  On the other hand, the purified 13 
IDO enzyme, which was prepared as previously reported,
25
 showed 0.30 U/mg of the 14 
specific activity to Met.  From these results, it was estimated that IDO-catalyst 15 
contained approximately 20% (w/w) of active form of IDO enzyme.   16 
The product of IDO-catalyst in the reaction mixture with Met was analyzed 17 
with the 1-fluoro-2-4-dinitrophenyl-5-L-alanine amide (FDAA) method for HPLC 18 
analysis and compared with the elution order of ()-MetSO reported previously.26  The 19 
product was then determined to be L-methionine (S)-sulfoxide [(+)-MetSO], as shown 20 
in Figure 1a and had >99% diastereomer excess (de).  Similarly, the product with Eth 21 
was analyzed using the FDAA method and determined to have >99% de.  According to 22 
the published data on L-ethionine sulfoxides in optical rotation and NMR 23 
measurements,
27
 the reaction product was determined to be L-ethionine (S)-sulfoxide 24 
6 
 
[(+)-EthSO], as shown in Figure 1a.  In order to identify the products of IDO-catalyst 1 
in the reaction mixtures with S-alkyl-L-cysteines such as SMCys, SECys, and SACys, 2 
they were analyzed with dansylchloride (Dns-Cl) methods for HPLC analysis and 3 
compared with the elution orders of ()-methiin, ()-ethiin, and ()-alliin reported 4 
previously
28
.  IDO-catalyst was thereby explained to convert SMCys, SECys, and 5 
SACys into S-methyl-L-cysteine (S)-sulfoxide [(+)-methiin], S-ethyl-L-cysteine 6 
(S)-sulfoxide [(+)-ethiin], and S-allyl-L-cysteine (S)-sulfoxide [(+)-alliin], respectively 7 
(Figure 1b).  Thus, IDO-catalyst catalyzed (S)-specific sulfoxidation of various 8 
sulfur-containing L-amino acids.  The stereoselectivity in the formations of these 9 
S-alkyl-L-cysteine sulfoxides was 88% de, 91% de, and 83% de, respectively.  These 10 
de values were lower than those of S-alkyl-L-homocysteine sulfoxides.  These 11 
differences in de values are caused by the relative position of the sulfur atom in amino 12 
acid molecules.  IDO-catalyzed oxidation proceeded more stereospecifically using 13 
amino acids with a sulfur atom at the δ-position than those at the γ-position.  It was 14 
inconsistent with our previous observation that IDO catalyzed absolutely stereoselective 15 
γ-hydroxylation of some L-amino acids.25   16 
 17 
2.2. Effects of pH and temperature on activities and stabilities of IDO-catalyst 18 
Thus, IDO-catalyst is a good biocatalyst for asymmetric synthesis of chiral 19 
sulfoxides.  In order to identify the best conditions for the biocatalysis, the pH and 20 
temperature profiles of the IDO-catalyst were determined using the (+)-alliin as a 21 
representative product (Figure 2).  IDO-catalyst showed a pH optimum between 6.0 22 
and 7.0, and retained over 90% activity after 1 h-incubation at pH 7.0 to 9.0 (Figure 2a).  23 
Also, IDO-catalyst showed a temperature optimum at 28°C, and retained over 80% 24 
7 
 
activity after 1 h-incubation at 20 to 28°C (Figure 2b).  From these results, the best 1 
conditions for the bioconversion were set at pH 7.0 and 28°C.  So, it was found that 2 
IDO catalyzed two different oxidations of amino acids, sulfoxidation and hydroxylation, 3 
under the similar reaction conditions.
23
   4 
 5 
2.3. Preparative laboratory scale productions of chiral amino acid sulfoxides 6 
 The preparative laboratory scale productions of (+)-MetSO, (+)-methiin, 7 
(+)-ethiin, and (+)-alliin from L-amino acids were carried out under optimal conditions.  8 
As shown in Figure 3, each product was formed from 50 mM of substrate for 4 h, 9 
resulting in an almost stoichiometric conversion of L-amino acid substrates to products.  10 
Among them, Met was the best substrate of IDO-catalyst and 47 mM of (+)-MetSO was 11 
produced from 50 mM of Met (94% yield with >99% de) in the 4-h reaction (Table 2).  12 
Estimated total turnover number of IDO enzyme included in IDO-catalyst used was 13 
1,342 during this conversion.  Also, SMCys and SECys were linearly converted into 14 
(+)-methiin and (+)-ethiin, and then the product amount reached 32 mM (64% yield 15 
with 93% de) and 43 mM (86% yield with 95% de) in the reaction, respectively.  In 16 
particular, (+)-ethiin content is very low in the tissue of Allium species
29
 and its own 17 
function has not been defined yet.  It was expected that (+)-ethiin also have valuable 18 
physiological properties as well as (+)-methiin and (+)-alliin.  In contrast, the 19 
conversion of SACys proceeded linearly until 2 h but weakened after 2 h, and then only 20 
35 mM of (+)-alliin was produced (70% yield with 81% de).  A high concentration of 21 
(+)-alliin (about >30 mM) may have inhibited the sulfoxidation activity of IDO-catalyst.   22 
 23 
3. Conclusion 24 
8 
 
Asymmetric oxidation of sulfur-containing L-amino acid with IDO-catalyst 1 
proved a very efficient way to produce various chiral amino acid sulfoxides, including 2 
(+)-methiin and (+)-alliin, which show noteworthy physiological activities in mammals.  3 
The dried cell powder of IDO-expressing E. coli was a handy biocatalyst because it was 4 
sufficiently stable to sustain the oxidation activity for several hours.  With our method 5 
established in this study, preparative laboratory scale productions of chiral sulfoxides 6 
with high optical purity could easily be provided through bioconversion, allowing 7 
further to development of their industrial applications. 8 
 9 
4. Experimental Section 10 
 11 
4.1. General Information 12 
 All reagents and solvents were as obtained by commercial source.  Reactions 13 
were monitored by thin-layer chromatography (TLC) which was performed with 14 





C NMR were recorded on an Avance 500 (BrukerBioSpin, MA, USA).  16 
D2O solutions were used for 
1
H NMR analysis.  D2O solutions containing acetone as 17 
an internal standard were used for 
13
C NMR analysis.  Chemical shifts are reported in 18 
parts per million (ppm, δ) relative to residual solvent signals (H2O, δ 4.79) or relative to 19 
acetone (δ 30.89).  Coupling constants (J values) are given in Hz, and peak 20 
multiplicities are denoted by s (singlet), d (doublet), dd (doublet of doublets), m 21 
(multiplet), and t (triplet).  Optical rotation was measured with a JASCO DIP-370 22 




4.2. Chemicals 1 
()-MetSO was purchased from Sigma-Aldrich (St. Louis, USA), and ()-alliin 2 
and ()-methiin were purchased from LKT Laboratories, Inc. (St. Paul, USA).  In 3 
order to obtain ()-EthSO and ()-ethiin, Eth and SECys were oxidized in 30% (w/w) 4 
hydrogen peroxide for 24 h and hand dried under reduced pressure, respectively.   5 
 6 
4.3. Recombinant Bacterial Strain and Preparation of IDO-Catalyst 7 
 Escherichia coli Rosetta 2 (DE3) carrying pET-IDO (2e2) was used for enzyme 8 
expression.
25
  Recombinant E. coli cells were grown aerobically at 37°C and 300 rpm 9 
in 250 mL LB medium with ampicillin (50 μg/ml) and chloramphenicol (34 μg/ml).  10 
At an OD 600 =1.0, isopropyl-β-D-thiogalactopyranoside (IPTG) was added to a final 11 
concentration of 1 mM, and the cultures were incubated for 16 h at 28°C and 300 rpm.  12 
The cells were harvested by centrifugation (8000 × g, 30 min, 4˚C) and washed in 13 
physiological saline twice. The cell pellet was air-dried, dehydrated using silica gel, and 14 
pounded in a mortar to obtain dried cell powder as IDO-catalyst.   15 
 16 
4.4. Derivatization and HPLC Assay 17 
Amino acids were analyzed by HPLC after derivatization with 18 
1-fluoro-2-4-dinitrophenyl-5-L-alanine amide (FDAA)
26
 or dansylchloride (Dns-Cl).
28
  19 
For the FDAA method, the derivatives were prepared by mixing 30 μl of the sample 20 
solution, 50 μl of 1% FDAA in acetone, and 10 μl of 1 M sodium bicarbonate.  The 21 
reaction mixture was heated at 40°C for 1 h, and then 5 μl of 2 M HCl was added.  The 22 
derivatized products were analyzed by HPLC.  HPLC analysis was performed with a 23 
Waters Alliance 2695 HPLC System (Waters, Milford, USA) equipped with a Beckman 24 
10 
 
Ultrasphere ODS column (5 μm, 250 × 4.6 mm, HiChrom, Reading, UK) and 1 
maintained at 40°C.  For analysis, 50 mM triethylamine phosphate (solvent A) and 2 
acetonitrile (solvent B) were used as the mobile phase, with a flow rate of 1 ml/min, the 3 
gradient of solvent B: 0-15 min: 15%; 15-30 min: 15%-22%; 30-33 min: 22-40%; 33-40 4 
min: 40%; 40-43 min: 40-15%; 43-47 min: 15%, and detection wavelength of 360 nm.  5 
The retention times of (+)-MetSO, (-)-MetSO, (+)-EthSO, and (-)-EthSO were 17.0, 6 
18.0, 22.1, and 23.4 min, respectively.  For the Dns-Cl method, the derivatives were 7 
prepared by mixing 100 μl of the sample solution, 250 μl of 10 mM Dns-Cl in 8 
acetonitrile, and 0.65 ml of a 20 mM borate buffer (pH 9.2).  The mixture was briefly 9 
shaken, allowed to stand at room temperature for 15 min, filtered through a 0.45 μm 10 
nylon filter, and analyzed by HPLC.  HPLC analysis was performed with a Waters 11 
Alliance 2695 HPLC System equipped with a Varian Microsorb MV C18 column (5 μm, 12 
250 × 4.6 mm, Agilent Technologies, Santa Clara, USA) and maintained at 40°C.  For 13 
analysis, 50 mM sodium acetate buffer (pH 5.0, solvent A) and methanol (solvent B) 14 
were used as the mobile phase, with a flow rate of 0.9 ml/min.  The gradient of solvent 15 
B is as follows: 0-35 min, 30%-40%; 35-60 min, 40%-75%; 60-65 min, 75%; 65-70 min, 16 
30%; and a detection wavelength of 250 nm.  The retention times of (-)-methiin, 17 
(+)-methiin, (-)-ethiin, (+)-ethiin, (-)-alliin, and (+)-alliin were 20.7, 25.5, 25.9, 31.5, 18 
31.5, and 38.9 min, respectively.   19 
 20 
4.5. Bioconversion of Sulfur-Containing Amino Acids with IDO-catalyst 21 
 IDO-catalyst was used for bioconversion of sulfur-containing amino acids.  22 
The standard reaction mixture contained 10 mM substrate, 15 mM α-ketoglutarate, 0.5 23 
mM FeSO4·7H2O, 2 mM ascorbate, 1 mM DTT, and 2 mg/ml (0.13 U/ml) IDO-catalyst 24 
11 
 
described above in 1 ml of a 50 mM Bis-Tris/HCl buffer (pH 6.0).  For the 1 
bioconversion of sulfur-containing amino acids, the mixture was slightly shaken at 28°C 2 
for 16 h.  The effects of pH on the activity were measured in the standard reaction 3 
mixture using SACys as a substrate at 28°C for 30 min, except 150 mM GTA buffer (50 4 
mM 3,3-dimethylglutaric acid, 50 mM Tris/HCl, 50 mM 5 
2-amino-2-methyl-1,3-propanediol, pH 4-10) was used instead of Bis-Tris/HCl buffer.  6 
The pH stability was examined in the standard reaction mixture by measuring the 7 
residual activity after incubation in GTA buffer for 1 h at 28°C.  The effects of 8 
temperature on the activity were measured in the standard reaction mixture using 9 
SACys as a substrate at 20-55°C for 30 min.  The temperature stability was examined 10 
in the standard reaction mixture by measuring the residual activity after incubation at 11 
each temperature for 1 h.  For the reparative laboratory scale productions of chiral 12 
amino acid sulfoxides, the reaction mixture contained 50 mM substrate, 100 mM 13 
α-ketoglutarate, 0.5 mM FeSO4·7H2O, 2 mM ascorbate, 1 mM DTT, and 5 mg/ml (0.32 14 
U/ml) of IDO-catalyst in 1 ml of a 50 mM Tris/HCl buffer (pH 7.0).  The mixture was 15 
slightly shaken at 28°C.  After 0, 1, 2, and 4 h of incubation, 50 μl aliquots were taken 16 
and added to an equal volume of 20 mM ethylenediamine-N,N,N',N'-tetraacetic acid 17 
(EDTA).  The concentrations of amino acid sulfoxides produced were determined with 18 
HPLC and 
1
H-NMR. All measurements were performed at least three times.   19 
 20 
4.6. Isolation of Oxidized Amino Acid Products 21 
The reaction mixtures were adjusted to pH 2.0 with 1 M HCl and applied to 22 
positive ion exchange resin (DOWEX 50W×8; Dow Chemical, Midland, USA), which 23 
was previously equilibrated with distilled water, and were eluted with 1 M NH3 solution.  24 
12 
 
The fractions containing oxidized amino acid products were passed through negative 1 
ion exchange resin (DOWEX 2×8), which was previously equilibrated with distilled 2 
water, and were eluted with 1 M HCl.  The fractions containing the products were 3 
combined, freeze-dried, and dissolved in D2O.  Isolated yields after purification were 4 
90, 88, 79, 70, and 65% for MetSO, EthSO, methiin, ethiin, and alliin, respectively.   5 
 6 
4.7 L-Methionine (S)-sulfoxide [(+)-MetSO] 7 
 
1
H NMR (500 MHz, D2O) δ: 2.30 (dd, J = 14.35, 7.75 Hz, 2H), 2.73 (s, 3H), 8 
2.95-3.07 (m, 2H), 3.88 (t, J = 6.25 Hz, 1H).  
13
C NMR (125 MHz, D2O) δ :24.41, 9 
37.21, 48.95, 54.01, 173.79.  [α]D
25





4.8. L-Ethionine (S)-sulfoxide [(+)-EthSO] 13 
 
1
H NMR (500 MHz, D2O) δ: 1.30 (t, J = 7.48 Hz, 3H), 2.28-2.32 (m, 2H), 14 
2.86-2.93 (m, 1H), 2.95-3.01 (m, 2H), 3.88 (t, J = 6.28 Hz, 1H).  
13
C NMR (125 MHz, 15 
D2O) δ: 6.58, 24.59, 45.08, 46.25, 54.04, 173.82.  [α]D
25
 +30.9 (c 0.1, H2O).  ESI-MS 16 




4.9. S-Methyl-L-cysteine (S)-sulfoxide [(+)-Methiin] 19 
 
1
H NMR (500 MHz, D2O) δ: 2.82 (s, 3H), 3.22 (dd, J = 13.87, 7.73 Hz, 1H), 20 
3.47 (dd, J = 13.93, 5.98 Hz, 1H), 4.18 (dd, J = 7.70, 6.05 Hz, 1H).  
13
C NMR (125 21 
MHz, D2O) δ: 38.79, 51.73, 53.88, 172.34.  [α]D
25







4.10. S-Ethyl-L-cysteine (S)-sulfoxide [(+)-Ethiin] 1 
 
1
H NMR (500 MHz, D2O) δ: 1.30 (t, J = 7.48 Hz, 3H), 2.91-2.97 (m, 1H), 2 
3.02-3.08 (m, 1H), 3.19 (dd, J = 13.95, 7.75 Hz, 1H), 3.43 (dd, J = 13.93, 5.98 Hz, 1H), 3 
4.20 (dd, J = 7.40, 6.35 Hz, 1H).  
13
C NMR (125 MHz, D2O) δ: 6.42, 46.52, 51.05, 4 
51.70, 172.31.  [α]D
25




4.11. S-Allyl-L-cysteine (S)-sulfoxide [(+)-Alliin] 7 
 
1
H NMR (500 MHz, D2O) δ: 3.21 (dd, J = 13.95, 7.65 Hz, 1H), 3.42 (dd, J = 8 
13.90, 6.30 Hz, 1H), 3.63 (dd, J = 13.38, 8.00 Hz, 1H), 3.84 (dd, J = 13.45, 6.90 Hz, 9 
1H), 4.18 (dd, J = 7.45, 6.38 Hz, 1H), 5.48 (dd, J = 17.08, 1.08 Hz, 1H), 5.54 (d, J = 10 
10.15 Hz, 1H), 5.87-5.95 (m, 1H).  
13
C NMR (125 MHz, D2O) δ: 50.59, 51.56, 55.79, 11 
125.11, 125.94, 172.31.  [α]D
25
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Figure legends 1 
 2 
Figure 1.  Asymmetric oxidation of sulfur-containing L-amino acids by IDO-catalyst.  3 
Highly selective (S)-configured sulfoxidation of S-alkyl-L-homocysteins (a) and 4 
S-alkyl-L-cysteines (b).   5 
 6 
Figure 2.  Effects of pH and temperature on activity and stability of (+)-alliin 7 
formation with IDO-catalyst.  For the each reaction, 10 mM SACys and 0.13 U/ml 8 
IDO-catalyst was used.  (a) The effects of pH on the activity and stability.  (b) The 9 
effects of temperature on the activity and stability.   10 
Figure 3.  Preparative laboratory productions of chiral amino acid sulfoxides. 11 
For the each reaction, 50 mM substrate and 0.32 U/ml IDO-catalyst was used.  All 12 
measurements were performed at least three times.  (+)-MetSO (○), (+)-methiin (□), 13 











Configuration of sulfinyl group de (%) 
Met FDAA 100 (S) >99 
Eth FDAA 67 (S) >99 
SMCys Dns-Cl 96 (S) 88 
SECys Dns-Cl 100 (S) 91 
SACys Dns-Cl 100 (S) 83 
 3 
  4 
19 
 
Table 2.  Preparative laboratory productions of chiral amino acid sulfoxides with 1 
IDO-catalyst 2 
 3 
Sulfoxide Produced (mM) Yield (%) de (%) 
(+)-MetSO 47 94 >99 
(+)-Methiin 32 64 93 
(+)-Ethiin 43 86 95 
(+)-Alliin 35 70 81 
 4 
 5 
  6 
20 
 

























[α]D +67.3 (c 0.1, H2O).  
Absolute configuration: (2S,(S)S) 








[α]D +30.9 (c 0.1, H2O).  
Absolute configuration: (2S,(S)S) 








[α]D +96.1 (c 0.1, H2O).  
Absolute configuration: (2S,(S)S) 








[α]D +40.0 (c 0.1, H2O).  
Absolute configuration: (2S,(S)S) 








[α]D +31.3 (c 0.1, H2O).  
Absolute configuration: (2S,(S)S) 
Source of chirality: S-allyl-L-cysteine, enzymatic sulfoxidation 
 
Stereochemistry Abstract
